JZ

Jiuyang Zhao

ST Shenzhen Targetrx: 6 patents #3 of 5Top 60%
Overall (2022): #22,160 of 548,613Top 5%
6
Patents 2022

Issued Patents 2022

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
11453672 Substituted pyrazolo[1,5-a]pyrimidines as tropomyosin receptor kinase inhibitors Yihan Wang 2022-09-27
11447512 Antiviral nucleoside reverse transcriptase inhibitor Yihan Wang 2022-09-20
11389463 Antiviral nucleoside reverse transcriptase inhibitor Yihan Wang 2022-07-19
11358973 Di(hetero)aryl macrocyclic compound for inhibiting protein kinase activity Yihan Wang, Yixin Ai 2022-06-14
11345703 Substituted pyrazolo[1,5-a]pyrimidine macrocyclic compound Yihan Wang 2022-05-31
11319317 (Hetero)arylamide compound for inhibiting protein kinase activity Yihan Wang, Yixin Ai 2022-05-03